Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy

NCT06490068 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: LTC004+Toripalimab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences